John E. Knox

1.9k total citations
27 papers, 767 citations indexed

About

John E. Knox is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, John E. Knox has authored 27 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Organic Chemistry and 8 papers in Oncology. Recurrent topics in John E. Knox's work include Metal complexes synthesis and properties (6 papers), Ubiquitin and proteasome pathways (5 papers) and Mosquito-borne diseases and control (4 papers). John E. Knox is often cited by papers focused on Metal complexes synthesis and properties (6 papers), Ubiquitin and proteasome pathways (5 papers) and Mosquito-borne diseases and control (4 papers). John E. Knox collaborates with scholars based in United States, Singapore and Switzerland. John E. Knox's co-authors include H. Bernhard Schlegel, Thomas H. Keller, Charles H. Winter, Mary Jane Heeg, Subhash G. Vasudevan, Sejal Patel, Zheng Yin, Siew Pheng Lim, Ngai Ling and David Beer and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Cancer Research.

In The Last Decade

John E. Knox

27 papers receiving 742 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John E. Knox United States 16 248 195 181 163 128 27 767
Laurent Fraisse France 20 349 1.4× 338 1.7× 356 2.0× 133 0.8× 166 1.3× 34 1.1k
Adonis Stassinopoulos United States 21 127 0.5× 327 1.7× 160 0.9× 155 1.0× 77 0.6× 47 1.1k
Agathe Urvoas France 20 124 0.5× 471 2.4× 183 1.0× 110 0.7× 73 0.6× 42 1.0k
Karine Barral France 13 223 0.9× 429 2.2× 428 2.4× 377 2.3× 37 0.3× 24 1.2k
Sara K. Madsen United States 7 537 2.2× 206 1.1× 129 0.7× 74 0.5× 90 0.7× 7 945
Krzysztof Felczak United States 20 126 0.5× 637 3.3× 241 1.3× 306 1.9× 103 0.8× 50 1.1k
Subramaniam Sujatha India 18 53 0.2× 105 0.5× 104 0.6× 121 0.7× 124 1.0× 55 866
Zhennan Zhao China 17 101 0.4× 230 1.2× 129 0.7× 121 0.7× 154 1.2× 32 835
Beatriz Baragaña United Kingdom 14 111 0.4× 329 1.7× 329 1.8× 71 0.4× 46 0.4× 24 685
Faustine Dubar France 19 193 0.8× 323 1.7× 665 3.7× 232 1.4× 314 2.5× 27 1.1k

Countries citing papers authored by John E. Knox

Since Specialization
Citations

This map shows the geographic impact of John E. Knox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Knox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Knox more than expected).

Fields of papers citing papers by John E. Knox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John E. Knox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Knox. The network helps show where John E. Knox may publish in the future.

Co-authorship network of co-authors of John E. Knox

This figure shows the co-authorship network connecting the top 25 collaborators of John E. Knox. A scholar is included among the top collaborators of John E. Knox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John E. Knox. John E. Knox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tomlinson, Aidan C.A., John E. Knox, Luc Brunsveld, Christian Ottmann, & Jason K. Yano. (2025). The “three body solution”: Structural insights into molecular glues. Current Opinion in Structural Biology. 91. 103007–103007. 4 indexed citations
2.
Knox, John E., G. Leslie Burnett, Caroline E. Weller, et al.. (2024). Abstract ND03: Discovery of RMC-9805, an oral, covalent tri-complex KRASG12D(ON) inhibitor. Cancer Research. 84(7_Supplement). ND03–ND03. 12 indexed citations
3.
Cregg, Jim, Yu Chi Yang, Christopher J. Schulze, et al.. (2023). Abstract ND07: Discovery of RMC-6291, a tri-complex KRASG12C(ON) inhibitor. Cancer Research. 83(7_Supplement). ND07–ND07. 4 indexed citations
4.
Nichols, Robert J., Yu Chi Yang, Jim Cregg, et al.. (2022). Abstract 3595: RMC-6291, a next-generation tri-complex KRASG12C(ON) inhibitor, outperforms KRASG12C(OFF) inhibitors in preclinical models of KRASG12C cancers. Cancer Research. 82(12_Supplement). 3595–3595. 27 indexed citations
5.
Knox, John E., Jingjing Jiang, G. Leslie Burnett, et al.. (2022). Abstract 3596: RM-036, a first-in-class, orally-bioavailable, Tri-Complex covalent KRASG12D(ON) inhibitor, drives profound anti-tumor activity in KRASG12D mutant tumor models. Cancer Research. 82(12_Supplement). 3596–3596. 26 indexed citations
6.
Sacco, M., Xiujun Zhang, Sophie E. Darch, et al.. (2019). Discovery of dual-activity small-molecule ligands of Pseudomonas aeruginosa LpxA and LpxD using SPR and X-ray crystallography. Scientific Reports. 9(1). 15450–15450. 23 indexed citations
7.
Li, Xiaojin, Ujjini H. Manjunatha, Michael Goodwin, et al.. (2008). Synthesis and antitubercular activity of 7-(R)- and 7-(S)-methyl-2-nitro-6-(S)-(4-(trifluoromethoxy)benzyloxy)-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazines, analogues of PA-824. Bioorganic & Medicinal Chemistry Letters. 18(7). 2256–2262. 60 indexed citations
8.
Krastel, Philipp, E. Schmitt, Ai Ting Goh, et al.. (2008). Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis. Journal of Antimicrobial Chemotherapy. 62(4). 713–719. 79 indexed citations
9.
Knox, John E., Wai Yee Phong, Ngai Ling, et al.. (2007). Yellow fever virus NS3 protease: peptide-inhibition studies. Journal of General Virology. 88(8). 2223–2227. 29 indexed citations
10.
Knox, John E., Mathew D. Halls, Hrant P. Hratchian, & H. Bernhard Schlegel. (2006). Chemical failure modes of AlQ3-based OLEDs: AlQ3 hydrolysis. Physical Chemistry Chemical Physics. 8(12). 1371–1371. 63 indexed citations
11.
Keller, Thomas H., Yen‐Liang Chen, John E. Knox, et al.. (2006). Finding New Medicines for Flaviviral Targets. Novartis Foundation symposium. 277. 102–119. 40 indexed citations
12.
13.
Knox, John E., Mathew D. Halls, & H. Bernhard Schlegel. (2006). Guest Species/Discrete Carbon Nanotube Inner Phase Charge Transfer and ExternalIonization. Journal of Computational and Theoretical Nanoscience. 3(3). 398–404. 3 indexed citations
14.
Yin, Zheng, Sejal Patel, Weiling Wang, et al.. (2005). Peptide inhibitors of dengue virus NS3 protease. Part 2: SAR study of tetrapeptide aldehyde inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(1). 40–43. 128 indexed citations
16.
Knox, John E., et al.. (2004). Using Stationary Points on Potential Energy Surfaces to Model Intermolecular Interactions and Retention in Gas Chromatography. Chromatographia. 59(5-6). 329–334. 2 indexed citations
18.
Knox, John E., et al.. (2003). Synthesis, Structure, Bridge−Terminal Exchange Kinetics, and Molecular Orbital Calculations of Pyrazolate-Bridged Digallium Complexes Containing Bridging Phenyl Groups. Journal of the American Chemical Society. 125(37). 11152–11153. 9 indexed citations
19.
Knox, John E., et al.. (2002). Synthesis, Structure, and Molecular Orbital Calculations of (Pyrazolato)vanadium(III) Complexes − Understanding η2-Pyrazolato Ligand Coordination on d2 Metal Centers. European Journal of Inorganic Chemistry. 2002(9). 2327–2334. 22 indexed citations
20.
Swisher, Robert G., et al.. (1989). The Reactions of Silver(I) With Tetraaza Macrocyclic Ligands. Journal of Coordination Chemistry. 20(2). 101–107. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026